Free Trial
OTCMKTS:GNBT

Generex Biotechnology (GNBT) Stock Price, News & Analysis

Generex Biotechnology logo

About Generex Biotechnology Stock (OTCMKTS:GNBT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
60,924 shs
Market Capitalization
$73 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GNBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Generex Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

GNBT Stock News Headlines

Bloomage Biotechnology
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
Generex Creates Own Regulatory Reality
Generex Plans Reverse Stock Split
Generex Biotechnology Jumps
See More Headlines

GNBT Stock Analysis - Frequently Asked Questions

Shares of GNBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Generex Biotechnology investors own include SELLAS Life Sciences Group (SLS), (UNISQ) (UNISQ), Amgen (AMGN), VBI Vaccines (VBIV), Novavax (NVAX), iBio (IBIO) and Inovio Pharmaceuticals (INO).

Company Calendar

Today
7/11/2025
Fiscal Year End
7/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:GNBT
CIK
1059784
Employees
15
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$2.66 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
122,058,000
Free Float
79,094,000
Market Cap
$73 thousand
Optionable
Not Optionable
Beta
-0.07

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:GNBT) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners